Patents by Inventor Birgitte Stuer-Lauridsen

Birgitte Stuer-Lauridsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10702560
    Abstract: A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol antimicrobial activity against E. coli and Clostridium perfringens; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species Bacillus amyloliquefaciens. Some of the Bacillus amyloliquefaciens were further identified as Bacillus amyloliquefaciens subsp. amyloliquefaciens whereas others were identified as amyloliquefaciens subsp. plantarum. A Bacillus strain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: July 7, 2020
    Assignee: CHR. HANSEN A/S
    Inventors: Beatrice Nielsen, Mette Dines Cantor, Birgitte Stuer-Lauridsen, Patrick Derkx, Eric Johansen
  • Publication number: 20180200309
    Abstract: A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol antimicrobial activity against E. coli and Clostridium perfringens; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species Bacillus amyloliquefaciens. Some of the Bacillus amyloliquefaciens were further identified as Bacillus amyloliquefaciens subsp. amyloliquefaciens whereas others were identified as amyloliquefaciens subsp plantarum. A Bacillus strain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.
    Type: Application
    Filed: December 8, 2017
    Publication date: July 19, 2018
    Applicant: Chr. Hansen A/S
    Inventors: Beatrice Nielsen, Mette Dines Cantor, Birgitte Stuer-Lauridsen, Patrick Derkx, Eric Johansen
  • Patent number: 9844573
    Abstract: A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol; (ii) antimicrobial activity against E. coli and Clostridium perfringens; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species Bacillus amyloliquefaciens. Some of the Bacillus amyloliquefaciens were further identified as Bacillus amyloliquefaciens subsp. amyloliquefaciens whereas others were identified as amyloliquefaciens subsp. plantarum. A Bacillus strain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: December 19, 2017
    Assignee: CHR. HANSEN A/S
    Inventors: Beatrice Nielsen, Mette Dines Cantor, Birgitte Stuer-Lauridsen, Patrick Derkx, Eric Johansen
  • Publication number: 20150079058
    Abstract: A Bacillus strain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol; (ii) antimicrobial activity against E. coli and Clostridium perfringens; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species Bacillus amyloliquefaciens. Some of the Bacillus amyloliquefaciens were further identified as Bacillus amyloliquefaciens subsp. amyloliquefaciens whereas others were identified as amyloliquefaciens subsp. plantarum. A Bacillus strain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.
    Type: Application
    Filed: April 11, 2013
    Publication date: March 19, 2015
    Applicant: Chr. Hansen A/S
    Inventors: Beatrice Nielsen, Mette Dines Cantor, Birgitte Stuer-Lauridsen, Patrick Derkx, Eric Johansen
  • Patent number: 8137950
    Abstract: A lactic acid bacterium (LAB) wherein an YjaE protein is essentially inactive and the LAB thereby get improved resistance to bacteriophages, a starter culture composition comprising the lactic acid bacterium and use of this starter culture manufacturing a food or feed product.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: March 20, 2012
    Assignee: Chr. Hansen A/S
    Inventors: Birgitte Stuer-Lauridsen, Thomas Janzen
  • Publication number: 20110223251
    Abstract: The present invention relates to a bacterial composition which has a long shelf-life, and a process for producing such compositions. The invention further relates to food products comprising the bacterial composition.
    Type: Application
    Filed: August 27, 2009
    Publication date: September 15, 2011
    Inventors: Susanne Abrahamsen, Birgitte Stuer-Lauridsen, Mette Winning, Lasse Vigel Joergensen, Iben Jeppesen, Peter Wagner
  • Publication number: 20080317903
    Abstract: A lactic acid bacterium (LAB) wherein an YjaE protein is essentially inactive and the LAB thereby get improved resistance to bacteriophages, a starter culture composition comprising the lactic acid bacterium and use of this starter culture manufacturing a food or feed product.
    Type: Application
    Filed: January 6, 2006
    Publication date: December 25, 2008
    Inventors: Birgitte Stuer-Lauridsen, Thomas Janzen